LIVN — LivaNova PLC
LIVN dilution and offerings
- Float: 54.9M shares
🔔 Alert me if LIVN files an offering or S-3
$80.21+1.57%
Last close: · regular session
Last 60 sessions
Float: 54.9M shares. Latest SEC filing: IRANNOTICE on Aug 5, 2026. LIVN closed at $80.21 (+1.57%) on Nov 2, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for LIVN in the TickerWise workspace.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: GB
- Exchange: NASDAQ
- Employees: 2,900
- Website: https://www.livanova.com
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
Latest SEC filings for LIVN
Latest LIVN news
- LivaNova PLC Q3 2026 Earnings Preview Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.